Compounding Parenteral Products in Pediatric Wards-Effect of Environment and Aseptic Technique on Product Sterility.

aseptic technique compounding parenteral products patient safety pediatrics sterility test

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
10 Aug 2021
Historique:
received: 21 06 2021
revised: 30 07 2021
accepted: 03 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 28 8 2021
Statut: epublish

Résumé

Parenteral products must be compounded using an aseptic technique to ensure sterility of the medicine. We compared the effect of three clinical environments as compounding areas as well as different aseptic techniques on the sterility of the compounded parenteral product. Clinical pharmacists and pediatric nurses compounded 220 samples in total in three clinical environments: a patient room, a medicine room and biological safety cabinet. The study combined four methods: observation, environmental monitoring (settle plates), monitoring of personnel (finger dab plates) and sterility testing (membrane filtration). Of the compounded samples, 99% were sterile and no significant differences emerged between the clinical environments. Based on the settle plates, the biological safety cabinet was the only area that fulfilled the requirements for eliminating microbial contamination. Most of the steps on the observation form for aseptic techniques were followed. All participants disinfected their hands, wore gloves and disinfected the septum of the vial. Non-contaminated finger dab plates were mostly detected after compounding in the biological safety cabinet. Aseptic techniques were followed relatively well in all environments. However, these results emphasize the importance of good aseptic techniques and support the recommendation of compounding parenteral products in biological safety cabinets in clinical environments.

Identifiants

pubmed: 34442162
pii: healthcare9081025
doi: 10.3390/healthcare9081025
pmc: PMC8393854
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur J Hosp Pharm. 2017 May;24(3):175-181
pubmed: 31156932
Pediatr Int. 2010 Apr;52(2):208-12
pubmed: 19664012
Int J Pharm Compd. 2017 Nov-Dec;21(6):518-529
pubmed: 29220341
J Clin Microbiol. 2001 Jul;39(7):2634-6
pubmed: 11427581
Indian J Pediatr. 2016 Apr;83(4):285-8
pubmed: 26264633
Med J Malaysia. 2013;68(1):52-7
pubmed: 23466768
J Hosp Infect. 2005 Nov;61(3):213-8
pubmed: 16213372
Pediatr Infect Dis J. 2006 Jul;25(7):652-4
pubmed: 16804442
Interact Cardiovasc Thorac Surg. 2006 Oct;5(5):666-8
pubmed: 17670678
J Hosp Infect. 2013 Feb;83(2):160-3
pubmed: 23313030
Am J Health Syst Pharm. 2005 Nov 15;62(22):2386-92
pubmed: 16278330
J Perinatol. 2007 Nov;27(11):713-7
pubmed: 17805342
Int J Syst Evol Microbiol. 2008 Nov;58(Pt 11):2560-4
pubmed: 18984693
J Hosp Infect. 2015 Dec;91(4):306-18
pubmed: 26164526
Clin Infect Dis. 1999 Nov;29(5):1338-40
pubmed: 10524995
J Microbiol Immunol Infect. 1999 Mar;32(1):26-32
pubmed: 11561567
Einstein (Sao Paulo). 2018 Sep 17;16(3):eAO4146
pubmed: 30231142
Qual Saf Health Care. 2005 Jun;14(3):190-5
pubmed: 15933316
Eur J Clin Nutr. 2014 Aug;68(8):953-8
pubmed: 24667748
J Hosp Infect. 2016 Dec;94(4):358-360
pubmed: 27613440
Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12
pubmed: 23867487
Eur J Clin Pharmacol. 2019 May;75(5):609-617
pubmed: 30683970
Am J Health Syst Pharm. 2009 Nov 15;66(22):2032-6
pubmed: 19890087

Auteurs

Sonja Virtanen (S)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O.Box 56 (Viikinkaari 5E), University of Helsinki, FI-00014 Helsinki, Finland.

Karmen Kapp (K)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O.Box 56 (Viikinkaari 5E), University of Helsinki, FI-00014 Helsinki, Finland.

Maria Rautamo (M)

HUS Pharmacy, HUS Helsinki University Hospital and University of Helsinki, Stenbäckinkatu 9B, 00290 Helsinki, Finland.

Lotta Schepel (L)

HUS Pharmacy, HUS Helsinki University Hospital and University of Helsinki, Stenbäckinkatu 9B, 00290 Helsinki, Finland.

Carita Lindén-Lahti (C)

HUS Pharmacy, HUS Helsinki University Hospital and University of Helsinki, Stenbäckinkatu 9B, 00290 Helsinki, Finland.

Cristina D Cruz (CD)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O.Box 56 (Viikinkaari 5E), University of Helsinki, FI-00014 Helsinki, Finland.

Päivi Tammela (P)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O.Box 56 (Viikinkaari 5E), University of Helsinki, FI-00014 Helsinki, Finland.

Classifications MeSH